183 related articles for article (PubMed ID: 3258504)
1. Complement activation and HLA-B27.
Meri S; Partanen J; Leirisalo-Repo M; Repo H
Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
[TBL] [Abstract][Full Text] [Related]
2. Complement activation and endotoxin in sepsis.
Padalino P; Gardinali M; Pallavicini J; Chiara O; Bisiani G; Nespoli A
Prog Clin Biol Res; 1989; 308():277-82. PubMed ID: 2780700
[No Abstract] [Full Text] [Related]
3. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
Repo H; Leirisalo M; Tiilikainen A; Laitinen O
Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
[TBL] [Abstract][Full Text] [Related]
4. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
5. Detection of the terminal complement complex in patient plasma following acute myocardial infarction.
Langlois PF; Gawryl MS
Atherosclerosis; 1988 Mar; 70(1-2):95-105. PubMed ID: 3258520
[TBL] [Abstract][Full Text] [Related]
6. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
Haeger M; Bengtson A; Karlsson K; Heideman M
Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
[TBL] [Abstract][Full Text] [Related]
7. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
[TBL] [Abstract][Full Text] [Related]
8. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
Janatova J
Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
[No Abstract] [Full Text] [Related]
9. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
10. Complement activation in plasma exchange.
Lancet; 1988 Dec 24-31; 2(8626-8627):1464-5. PubMed ID: 2904577
[No Abstract] [Full Text] [Related]
11. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
Leirisalo M; Repo H; Tiilikainen A; Kosunen TU; Laitinen O
Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
[TBL] [Abstract][Full Text] [Related]
12. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome.
Langlois PF; Gawryl MS
Am Rev Respir Dis; 1988 Aug; 138(2):368-75. PubMed ID: 3264125
[TBL] [Abstract][Full Text] [Related]
13. Isolation of three separate anaphylatoxins from complement-activated human serum.
Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
[TBL] [Abstract][Full Text] [Related]
14. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
Koivuranta-Vaara P; Repo H; Leirisalo M; Kiistala U; Osterman T; Vapaatalo H
Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
[TBL] [Abstract][Full Text] [Related]
15. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
[TBL] [Abstract][Full Text] [Related]
16. Complement activation in type 1 human diabetes.
Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
[TBL] [Abstract][Full Text] [Related]
17. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
18. Complement activation and vascular injury in systemic lupus erythematosus.
Abramson S; Belmont HM; Hopkins P; Buyon J; Winchester R; Weissmann G
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():43-6. PubMed ID: 2886660
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
Takematsu H; Ohkohchi K; Tagami H
Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
[TBL] [Abstract][Full Text] [Related]
20. Complement activation in neonatal disease.
Zilow EP
Eur J Pediatr; 1993 May; 152(5):459-60. PubMed ID: 8319722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
